Reported Earlier, Mesoblast's FDA-Approved Ryoncil Gets IND Clearance For Registrational DMD Trial, To Randomize 76 Patients Aged 5-9 Years Across 7 Infusions Over 9 Months

Benzinga Newsdesk www.benzinga.com Positive 72.7%

Neg 0% Neu 0% Pos 72.7%

Partnering with Parent Project Muscular Dystrophy to ensure timely access to the trial for eligible patients

~15,000 children are living with DMD in the U.S.

Comments

No comments yet. Be the first!

Reported Earlier, Mesoblast&#39;s FDA-Approved Ryoncil Gets IND Clearance For Registrational DMD Trial, To Randomize 76 Patients Aged 5-9 Years Across 7 Infusions Over 9 Months